Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

PRD-125: a potent SOAT2 inhibitor ameliorates atherosclerosis in rabbits

Nov. 14, 2017

Phase II data presented for MEDI-6012 in patients with coronary heart disease

Nov. 14, 2017

Inotrem collaborates with Roche Diagnostics on septic shock companion diagnostic

Nov. 10, 2017

Bristol-Myers Squibb presents ROM-K channel blockers for hypertension

Nov. 7, 2017

Patient dosing begins in ORION-11 study of inclisiran

Nov. 7, 2017

Bayer seeks E.U. approval of rivaroxaban for patients with coronary or peripheral artery disease

Nov. 6, 2017

Moderna Therapeutics, AstraZeneca to develop AZD-7970 for heart failure

Nov. 6, 2017

Symic Bio reports results from SHIELD study of SB-030 in peripheral vascular disease

Nov. 2, 2017

Novel apelin receptor agonists synthesized at Bristol-Myers Squibb

Oct. 13, 2017

Athera initiates phase IIa trial of PC-mAB in patients with arterial inflammation

Oct. 13, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...